Skip to main content
Oncotarget logoLink to Oncotarget
. 2016 Dec 9;7(37):60775. doi: 10.18632/oncotarget.11976

Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients

Brian Grindel, Quanlin Li, Rebecca Arnold, John Petros, Majd Zayzafoon, Mark Muldoon, James Stave, Leland W K Chung, Mary C Farach-Carson
PMCID: PMC5312418  PMID: 28040804

Present section: Due to an error made during submission of the revised files, acknowledgements were omitted from this manuscript.

Correct section: Corrected acknowledgements information is provided below. Authors sincerely apologize for this oversight.

Original article: Oncotarget. 2016; 7(9):10433-47. doi: 10.18632/oncotarget.7197.

Acknowledgments

This team project was supported by theNational Institutes of HealthiNational Cancer Institute grant PO1 CA098912. We are indebted to the many members of our team who contributed to the work including especially Drs. Ann-Christine Olsen, Dror Berel, Billie E. Smith, Arek Arkadiusz, Beatrice Knudsen, Dan Harrington and Andre Rogatko. We thank all of the members of the laboratories of the POl for many helpful discussions as this work progressed.


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES